Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
Outlook Therapeutics reports 2023 executive compensation
By ExecPay News
Published: February 8, 2024
Outlook Therapeutics reported fiscal year 2023 executive compensation information on February 8, 2024.
In 2023, three executives at Outlook Therapeutics received on average a compensation package of $1.1M, a 23% decrease compared to previous year.
Average pay of disclosed executives at Outlook Therapeutics
C. Russell Trenary III, Chief Executive Officer, received $1.8M in total, which increased by 32% compared to 2022. 65% of Trenary's compensation, or $1.1M, was in option awards. Trenary also received $600K in salary and $11K in other compensation.
Terry Dagnon, Former Chief Operations Officer, received a compensation package of $728K, which decreased by 49% compared to previous year. 62% of the compensation package, or $450K, was in salary.
Jeff Evanson, Chief Commercial Officer, earned $718K in 2023, a 49% decrease compared to previous year.
Outlook Therapeutics' fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on February 8, 2024.